Monoamine oxidase inhibitors (MAOI) are actually recognized to prolong and improve the effects of dimethyltryptamine (copyright) and a person examine assumed that the impact on psilocybin could well be comparable since it is a structural analogue of copyright.[145] However, only a little percentage of psilocin appears to get metabolized by MAO.[16]